Treatment of Multiple Sclerosis With Anti-CD19 Antibody

The present invention provides for the treatment of multiple sclerosis through the use of chimeric and humanized versions of anti-CD19 antibodies that may mediate ADCC, CDC, and/or apoptosis.

Saved in:
Bibliographic Details
Main Authors KNAPPERTZ VOLKER ARMIN, CARTER LAURA LEE, WANG YUE, HERBST RONALD
Format Patent
LanguageEnglish
Published 12.02.2015
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention provides for the treatment of multiple sclerosis through the use of chimeric and humanized versions of anti-CD19 antibodies that may mediate ADCC, CDC, and/or apoptosis.
Bibliography:Application Number: US201314384714